Eleni Tamerat Belay

Form Technologies, Inc., a leading global group of precision component manufacturers, in a $1.2 billion comprehensive recapitalization and debt exchange transaction that eliminated approximately $240 million of total funded debt, including full repayment of Form Technologies’ second lien term loan, partial repayment of the first lien term loan, and an amendment and 3.5-year maturity extension of the $733 million the company’s first lien revolver and term loan debt. The transaction was funded through the proceeds of a $300 million new money preferred equity investment from its existing equity holders and certain of its lenders 

Bristol-Myers Squibb on its divestiture of the UPSA consumer health business to Taisho Pharmaceutical for $1.6 billion

Summer Associate, Kirkland & Ellis LLP, Summer 2017

Legal Intern, FedEx Ground Package System, Inc., Summer 2016

Marketing Specialist, VW Credit, Inc., Jan.–May 2015

Marketing Analyst, VW Credit, Inc., June–Dec. 2014

VCI Marketing Intern, Volkswagen Group of America, Summer 2013